However, our group has recently shown that CBX4 impairs Runx2 expression in CRC via recruiting HDAC3 to inhibit H3K27Ac at the Runx2 promoter, consequently impairing CRC metastasis12. This evidence concerns the gene CBX4 and colorectal carcinoma.